Combination of technologies to better select drug candidates and increase the drug development success.
ImaBiotech develops and integrates recent technologies to study the distribution of drug and biomarkers simultaneously. This integration of innovative imaging technologies allow to measure and quantify the impact of drugs to cells and the tissue microenvironment. We decipher the complexity of the tissue and allows to depict the full picture of the efficacy of a drug or the relevance of a biomarker from early discovery to clinical stages.
The multimodal imaging platform and image analysis includes:
- Different Multiplex Imaging Capabilities (Learn More)
- GeoMx Spatially resolved Gene expression (Learn More)
- Laser Capture Microdissection (Learn More)
- Digital pathology (Learn More)
- Multimaging Software solutions (Learn More)
- Imaging Mass Cytometry services also called High Multiplex ImmunoHisto Chemistry (Learn More)
- Exclusive Panel of Biomarkers (Create your own panel)
- Large Mass Spectrometry Platform (Learn more about the Pyxant Labs sister company)
With the integration of innovative spatially resolved technologies, we offer a wide range of services that includes: